SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-22-018607
Filing Date
2022-09-16
Accepted
2022-09-16 16:13:39
Documents
6
Period of Report
2022-11-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A eypt_pre_14a_09-16-2022.htm PRE 14A 1067741
2 GRAPHIC img55613222_0.jpg GRAPHIC 41162
3 GRAPHIC img55613222_1.jpg GRAPHIC 28889
4 GRAPHIC img55613222_2.jpg GRAPHIC 41162
5 GRAPHIC img55613222_3.jpg GRAPHIC 74103
6 GRAPHIC img55613222_4.jpg GRAPHIC 82125
  Complete submission text file 0000950170-22-018607.txt   1437601
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-51122 | Film No.: 221248202
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services